Recent Company News

• 05:51 AM ET Nov 25, 2025
  

  StreetAccount Summary - European unusual volume traders

• 09:18 AM ET Oct 16, 2025
  

  StreetAccount Summary - US Pre-market trading update

• 06:29 AM ET Nov 19, 2025
  

  Cellectis announces publication of article in Nature Communications on a non-viral gene editing process enabling efficient gene insertion in HSPCs (€3.84, +0.27)

• 04:32 PM ET Nov 07, 2025
  

  Cellectis SA reports Q3 EPS ($0.46) ex-items vs FactSet ($0.23) [6 est, ($0.37)-(0.09)] (€2.86, 0.00)

• 04:11 AM ET Oct 17, 2025
  

  StreetAccount Summary - Trading higher/lower: EU mid-morning

• 05:43 PM ET Oct 16, 2025
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 03:32 PM ET Oct 16, 2025
  

  Cellectis' R&D Day highlights lasme-cel's potential to address significant unmet need for patients with r/r b-all (€4.07, 0.00)

• 10:06 AM ET Oct 16, 2025
  

  StreetAccount Summary: Stocks reaching new 52-week highs/lows (200 total)